Oliver Schroeder

Oliver Schroeder has a diverse work experience spanning over several companies and roles. Oliver is currently working as the Business Unit Lead Medical Cannabis at Neuraxpharm since April 2022. Prior to this, they served as the Head of Marketing at Vayamed from July 2021 to May 2022. From December 2018 to January 2021, they held the position of Head of Product marketing/Head of Commercial Operations at Desitin Arzneimittel GmbH. Oliver also worked as the Global Head of Product management at Indivumed Group in September and November 2018. Oliver Schroeder's work experience includes roles such as Head of Marketing Germany, Austria and Switzerland at Medday Pharmaceuticals from July 2017 to August 2018, and as Head of Global Marketing Neurology/Head of Business Unit Neurology Germany at Almirall from June 2016 to June 2017. Oliver started their career as a Senior Product Manager at Boots Healthcare International in January 2002 and held various marketing roles there until March 2006. Prior to that, they worked as a Marketing Manager at LichtBlick die Zukunft der Energie GmbH from May 1999 to December 2001.

Oliver Schroeder attended Leuphana University of Lüneburg from 1989 to 1996, where they obtained a degree in Diplomkaufmann with a focus on Marketing. Prior to this, they completed their Abitur at Gymnasium Kaltenkirchen, although the specific years are not provided.